CURRENT TOPICS IN FREE RADICAL BIOLOGY and MEDICINE 
(FRRB:6006) 

Fall 2022

The University of Iowa 

11:30-12:30, Every Other Monday

B111 ML

 

Presentations for Fall 2022:

 

 

August 29, 2022

Presenter:  Corinne Griguer

Paper:  Wyart E, Hsu MY, Sartori R, Mina E, Rausch V, Pierobon ES, Mezzanotte M, Pezzini C, Bindels LB, Lauria A, Penna F, Hirsch E, Martini M, Mazzone M, Roetto A, Geninatti Crich S, Prenen H, Sandri M, Menga A, Porporato PE. Iron supplementation is sufficient to rescue skeletal muscle mass and function in cancer cachexia. EMBO Rep. 2022 Apr 5;23(4):e53746. Epub 2022 Feb 24. PMID: 35199910; PMCID: PMC8982578. doi: 10.15252/embr.202153746

 

September 12, 2022

Presenter:  Mekhla Singhania

Paper:  Córdova-Delgado M, Fuentes-Retamal S, Palominos C, López-Torres C, Guzmán-Rivera D, Ramírez-Rodríguez O, Araya-Maturana R, Urra FA. FRI-1 Is an Anti-Cancer Isoquinolinequinone That Inhibits the Mitochondrial Bioenergetics and Blocks Metabolic Shifts by Redox Disruption in Breast Cancer Cells. Antioxidants (Basel). 2021 Oct 14;10(10):1618. PMID: 34679752; PMCID: PMC8533268.

doi: 10.3390/antiox10101618

 

September 26, 2022

Presenter: Dr. Melissa Fath

Paper: Coelho DR, Palma FR, Paviani V, He C, Danes JM, Huang Y, Calado JCP, Hart PC, Furdui CM, Poole LB, Schipma MJ, Bonini MG. Nuclear-localized, iron-bound superoxide dismutase-2 antagonizes epithelial lineage programs to promote stemness of breast cancer cells via a histone demethylase activity. Proc Natl Acad Sci U S A. 2022 Jul 19;119(29):e2110348119. Epub 2022 Jul 14. PMID: 35858297; PMCID: PMC9303987. 

doi: 10.1073/pnas.2110348119

 

October 10, 2022

Presenter: Yuna Bayanbold

Paper:  Unlu G, Prizer B, Erdal R, Yeh HW, Bayraktar EC, Birsoy K. Metabolic-scale gene activation screens identify SLCO2B1 as a heme transporter that enhances cellular iron availability. Mol Cell. 2022 Aug 4;82(15):2832-2843.e7. Epub 2022 Jun 16. PMID: 35714613; PMCID: PMC9356996.

doi: 10.1016/j.molcel.2022.05.024.

 

October 24, 2022

Presenter:  Canceled

Paper: 

 

November 7, 2022

Presenter:  Akshaya Warrier

Paper: Lim JKM, Delaidelli A, Minaker SW, Zhang HF, Colovic M, Yang H, Negri GL, von Karstedt S, Lockwood WW, Schaffer P, Leprivier G, Sorensen PH. Cystine/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance. Proc Natl Acad Sci U S A. 2019 May 7;116(19):9433-9442. Epub 2019 Apr 18. PMID: 31000598; PMCID: PMC6511045.

doi: 10.1073/pnas.1821323116

 

November 21, 2022

Presenter:  Thanksgiving, No journal club

 

December 5, 2022

Presenter:  Amanda Pope

Paper: Mason JA, Cockfield JA, Pape DJ, Meissner H, Sokolowski MT, White TC, Valentín López JC, Liu J, Liu X, Martínez-Reyes I, Chandel NS, Locasale JW, Schafer ZT. SGK1 signaling promotes glucose metabolism and survival in extracellular matrix detached cells. Cell Rep. 2021 Mar 16;34(11):108821. PMID: 33730592.

doi: 10.1016/j.celrep.2021.108821